Perkins Coie Trust CO Eli Lilly & CO Transaction History

Perkins Coie Trust CO

$416 Million
Q2 2024

A detailed history of Perkins Coie Trust CO transactions in Eli Lilly & CO stock. As of the latest transaction made, Perkins Coie Trust CO holds 5,758 shares of LLY stock, worth $5.2 Million. This represents 1.25% of its overall portfolio holdings.

Number of Shares

5,758

Previous 4,445 29.54%

Holding current value

$5.2 Million

Previous $3.46 Million 50.75%

% of portfolio

1.25%

Previous 0.84%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 12, 2024	BUY	$724.87 - $909.04 $951,754 - $1.19 Million	1,313 Added 29.54%	5,758 $5.21 Million
Q1 2024 Apr 12, 2024	BUY	$592.2 - $792.28 $338,146 - $452,391	571 Added 14.74%	4,445 $3.46 Million
Q4 2023 Jan 09, 2024	BUY	$525.19 - $619.13 $1.78 Million - $2.1 Million	3,390 Added 700.41%	3,874 $2.26 Million
Q3 2023 Oct 11, 2023	BUY	$434.7 - $599.3 $13,041 - $17,979	30 Added 6.61%	484 $259,000
Q3 2021 Oct 13, 2021	SELL	$221.6 - $272.71 $62,934 - $77,449	-284 Reduced 38.48%	454 $105,000
Q2 2021 Jul 14, 2021	SELL	$180.55 - $233.54 $34,485 - $44,606	-191 Reduced 20.56%	738 $169,000
Q1 2021 Apr 13, 2021	SELL	$164.32 - $212.72 $52,582 - $68,070	-320 Reduced 25.62%	929 $174,000
Q4 2020 Jan 12, 2021	SELL	$130.46 - $172.63 $48,139 - $63,700	-369 Reduced 22.81%	1,249 $211,000
Q3 2020 Oct 13, 2020	SELL	$146.22 - $169.13 $58,488 - $67,652	-400 Reduced 19.82%	1,618 $239,000
Q2 2020 Jul 13, 2020	SELL	$136.42 - $164.18 $54,567 - $65,672	-400 Reduced 16.54%	2,018 $331,000
Q1 2020 Apr 10, 2020	BUY	$119.05 - $147.35 $49,524 - $61,297	416 Added 20.78%	2,418 $335,000
Q2 2019 Jul 10, 2019	BUY	$110.79 - $129.32 $44,316 - $51,728	400 Added 24.97%	2,002 $222,000
Q3 2017 Oct 13, 2017	BUY	$77.07 - $85.54 $123,466 - $137,035	1,602	1,602 $137,000

Others Institutions Holding LLY

# of Institutions

3,865

Shares Held

751M

Call Options Held

6.34M

Put Options Held

7.97M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $858B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Perkins Coie Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Perkins Coie Trust CO with notifications on news.

Account

Perkins Coie Trust CO Eli Lilly & CO Transaction History